44results about How to "Promotes collagen production" patented technology

The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.

A method for treating skin may first involve contacting an applicator of a skin heating device with an epidermal layer of the skin. The applicator may be activated to generate high-frequency alternating magnetic fields. The applicator may be used to heat a dermal layer of the skin, with the high-frequency alternating magnetic fields, to a temperature of less than 40 degrees Celsius, to stimulate a release of heat shock protein in the dermal layer to promote collagen generation. The method may also involve limiting heating of the dermal layer of the skin to less than 40 degrees Celsius.

The present invention relates to skin care compositions providing a method of enhancing the remodeling of age damaged and sun damaged skin in mammals utilizing an elastin peptide (EP) ligand of the general formula (GXXPG)n and in particular the sequences of (VGVAPG)n and/or (GVAPGV)n, and/or (VAPGVG)n and/or (APGVGV)n and/or (PGVGVA)n and/or (GVGVAP)n and a galactosugar which modulates the effect of the elastin peptide ligand(EP) on its lectin the Elastin-Binding Receptor (EBR). wherin A is a peptide-forming residue of L-alanine; G is a peptide-forming residue of glycine P is a peptide-forming residue of L-proline V is a peptide-forming residue of L-valine X is a peptide-forming residue of a single unspecified amino acid

Peptide representations in this application conform to the standard practice of writing the NH₂-terminal amino acid residue at the left of the formula and the CO₂ H-terminal amino

acid residue at the right.

An apparatus is disclosed including: an incoherent light source that generates a treatment beam having a non-uniform energy profile, the non-uniform energy profile being included of regions of relatively high energy per unit area within a substantially uniform background region of relatively low energy per unit area.

A topical compound for reducing sagging or wrinkles in the neck area of human skin. The compound includes safe and effective amounts of a mild topical astringent (such as Camphor) for skin tightening, a topical antispasmodic (such as benzyl cinnamate) for skin smoothing, and a topical skin irritant to increase localized skin circulation. The compound can also optionally include palmitoyl pentapeptide-3 to stimulate production of collagen and elastin in skin, a mushroom ferment extract to increase the cell turnover rate skin, and to increase hydration, skin firmness and elimination of fine facial lines, a cocao ferment extract to inhibit lipid peroxidation, inhibit excess ornithine decarboxylase activity, and stimulate cutaneous blood flow to reduce lines and wrinkles, and a Lactobacillus lysate extract to stimulate collagen production. These ingredients are mixed in a dermatologically acceptable carrier for topical application.

The present embodiments relate to methods and systems for identifying areas of a subject's skin that lack sufficient volume. In some embodiments, this can be used to direct the administration of filler compositions or the application of techniques that increase the volume or firmness of the area. In some embodiments, the methods and systems provide for improved aesthetic benefit as well as suitability for instruction and training. In some embodiments, the methods are especially useful in the administration of dermal fillers to a subject.

The device for the treatment of the vaginal canal by a laser beam, comprises a vaginal canal wall retractor, associated to a system for directing the laser beam towards said wall.

The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.

An accelerator of collagen production containing a compound represented by formula (I) or a salt thereof

wherein the three dotted lines represent two single bonds and one double bond.

The invention discloses an oxygen ion suspension nanometer gold foil stock solution and a preparation method of the oxygen ion suspension nanometer gold foil stock solution, and mainly relates to the field of a skin care product. The oxygen ion suspension nanometer gold foil stock solution comprises the following ingredients in percentage by weight: 30 percent to 40 percent of deionized water, 10 percent to 18 percent of hyaluronic acid, 10 percent to 15 percent of water-solubility collagen, 10 percent to 20 percent of levo Vc, 5 percent to 8 percent of allantoin, 1 percent to 3 percent of sorbitol, 0.1 percent to 1 percent of carbomer, 1 percent to 3 percent of PPG (polypropylene glycol)-4 cetanol polyether-20, 15 percent to 25 percent of gold foil and 3 percent to 5 percent of negative oxygen ions. The oxygen ion suspension nanometer gold foil stock solution has the advantages that good whitening, moisture preserving and anti-wrinkle antioxidation efficacies are achieved; the gold foil can be uniformly suspended; the conduction and revitalizing functions of the gold foil are fully exerted; the water curing performance is obviously improved.

It has been discovered that granulocyte macrophage colony stimulating factor (“GM-CSF”) promotes migration of activated (but not differentiating) keratinocytes to wound sites. It was also discovered that GM-CSF increases the quantity and improves the quality of collagen. This growth factor specifically increases migration of keratinocytes of the “wound” phenotype but does not have significant effects upon differentiated keratinocytes. Examples demonstrate reversal of skin impairment in multiple animal models of diabetic skin imparment when provided in an effective amount over an effective time period. The examples also demonstrate the efficacy of the formulations in cosmetic applications. A preferred formulation is a sustained release formulation that delivers sufficient growth factor to the skin and the underlying tissue thereof to increase the rate of keratinocyte migration, as well as collagen deposition and fibroblast proliferation, in the skin to promote rejuvenation of skin injuries resistant to repair due to underlying disease, such as diabetes, or aging.

The present invention relates to a skin cosmetic product containing 3,9-diferulylcoumestrol, especially to a skin cosmetic product containing a compound in which ferulylic acid is bonded to a coumestrol. The skin cosmetic product has several excellent effects for improving cosmetic disorders, such as anti-aging effect, whitening effect and hair-seeding effect.

The present invention relates to a cosmetic active ingredient for improving the appearance of the skin beneath the eyes. More particularly, the present invention relates to a cosmetic active ingredient comprising an extract of the marine algae, Fucus vesiculosus. The present invention also relates to topical cosmetic compositions comprising as an active component an extract of the marine algae, Fucus vesiculosus, alone or in combination with additional cosmetic active ingredients, to reduce the appearance of dark circles in skin beneath the eye.

Disclosed are compositions and methods for their use for reducing tumor necrosis factor alpha (TNF-α) and/or vascular endothelial growth factor (VEGF) production in skin cells by topically applying to skin in need thereof, a composition comprising an effective amount of Opuntia ficus-indica tuna, Opuntia ficus-indica nopales, or both, or extracts thereof, to reduce TNF-α or VEGF production in skin cells.

The present invention provides compounds and pharmaceutical compositions adapted to reduce a load of an RNA virus by at least 50%, the virus causing a pathogenic disease in a mammalian subject, the compound adapted to inhibit the formation of S-adenosyl methionine (SAM) in the virus, the compound being a DOTIL inhibitor, wherein the compound has a molecular weight of less than 1000, and a therapeutic index (TI=ED₅₀/LD₅₀) greater than 30 in the mammalian subject.

The present disclosure provides a fermentation product of Punica granatum and methods for regulating expression of MMP gene, TIMP gene and COL4A4 gene, promoting collagen production, and anti-aging by using the fermentation product of Punica granatum.